Entering text into the input field will update the search result below

Premarket analyst action - healthcare

  • Marinus Pharmaceuticals (NASDAQ:MRNS) initiated with Buy rating and $33 (443% upside) price target at H.C. Wainwright. Shares up 4% premarket.
  • Arsanis (NASDAQ:ASNS) initiated with Overweight rating with a $26 (111% upside) price target at Cantor Fitzgerald.
  • PolarityTE (COOL) initiated with Overweight rating and $70 (245% upside) price target at Cantor. Shares up 17% premarket.
  • Adverum Biotechnologies (NASDAQ:ADVM) resumed with Overweight rating and $12 (85% upside) price target at Piper Jaffray. Shares up 5% premarket.
  • Henry Schein (NASDAQ:HSIC) resumed with Neutral rating and $77 (13% upside) price target at JPMorgan. Shares down 1% premarket.
  • Atara Biotherapeutics (NASDAQ:ATRA) downgraded to Sell at Citigroup. Shares down 6% premarket.

Recommended For You

More Trending News

About MRNS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MRNS--
Marinus Pharmaceuticals, Inc.